About: Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 September 2003

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована у вересні 2003 (uk) im September 2003 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en setiembre de 2003 (ast) scientific article published on 01 September 2003 (en)
publication date	wds:Q73903671-47913EE2-14AF-4655-A543-E912CE968FC1
publication date	2003-09-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q73903671-AC0E894E-CDF4-4F8F-8606-9EE35243607C
language of work or name	English
cites work	wds:Q73903671-0A108D17-83A7-45B8-AA0D-753BB54346F5 wds:Q73903671-0D599609-6ACF-450F-9230-145BE9246FD4 wds:Q73903671-0F834B50-9AF6-4290-899D-7F718687258C wds:Q73903671-11328468-5720-4216-AC17-3ACA2DC91248 wds:Q73903671-1453D417-028B-4687-8426-943EA0568463 wds:Q73903671-1C986165-DF6D-4631-B11C-8AFD3ECBEDBA wds:Q73903671-1F5736EE-59C0-4109-88D1-646A3FF3B34D wds:Q73903671-2AEF246F-1CCC-4727-A7E1-91CDC1486B90 wds:Q73903671-4173E467-9295-4E3C-BCF1-78EA287D4FDE wds:Q73903671-6BCA0685-A57A-4BE2-B804-3688B4B8D1F3 wds:Q73903671-8E130E4F-CCA2-472D-BD05-722EC6CAF3C3 wds:Q73903671-9CE9061F-0C22-4A74-B9BA-9BEB057F7B64 wds:Q73903671-A5D76BFD-52FE-418D-A2CE-3ED5670369CC wds:Q73903671-B575B9BB-4FDC-4B8E-8245-DB081166F055 wds:Q73903671-D1826BEC-4FC5-4E53-AE4F-2BBD11B5749D wds:Q73903671-D8F0ED48-6875-402B-9557-63E753903CDD wds:Q73903671-DF5D5030-F571-48AE-9022-4D0CA7A567A7 wds:Q73903671-F17E8097-FB2D-4159-9BC4-2E4118549DCD wds:Q73903671-FF2A96F4-83E3-4465-8685-0A548F7D020B wds:Q73903671-FF99ACD5-58F1-4F10-A1F2-6B417B630004
cites work	Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor. Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort. An inhibitor of activated thrombin-activatable fibrinolysis inhibitor potentiates tissue-type plasminogen activator-induced thrombolysis in a rabbit jugular vein thrombolysis model Purification and characterization of TAFI, a thrombin-activable fibrinolysis inhibitor Thrombin activatable fibrinolysis inhibitor and an antifibrinolytic pathway Plasma thrombin-activatable fibrinolysis inhibitor antigen concentration and genotype in relation to myocardial infarction in the north and south of Europe Identification of polymorphisms in the promoter and the 3' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled Two naturally occurring variants of TAFI (Thr-325 and Ile-325) differ substantially with respect to thermal stability and antifibrinolytic activity of the enzyme. Insulin resistance is associated with increased circulating level of thrombin-activatable fibrinolysis inhibitor in type 2 diabetic patients Assay of protein C in human plasma: comparison of amidolytic, coagulation, and immunochemical assays Determination of functional and antigenic protein C inhibitor and its complexes with activated protein C in plasma by ELISA's Thr325IIe polymorphism of the TAFI gene does not influence the risk of myocardial infarction A novel, possibly functional, single nucleotide polymorphism in the coding region of the thrombin-activatable fibrinolysis inhibitor (TAFI) gene is also associated with TAFI levels Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAFI gene polymorphisms Inducible carboxypeptidase activity. A role in clot lysis in vivo
author name string	wds:Q73903671-00E12444-020F-440C-BC16-90B3327573EF wds:Q73903671-0C6048D5-7DE9-457E-9CF3-3F3AABEACF4F wds:Q73903671-1FA32F4E-CC71-4FF4-8767-BAFFC9681AF4 wds:Q73903671-3A7966B8-3F3F-4C1B-8C1F-4E68CB125287 wds:Q73903671-4BFD83A7-3F59-4C98-9014-BE5F0008A230 wds:Q73903671-67E8EC74-15AB-4266-B3EC-F59E00F1D306 wds:Q73903671-A73FE39D-47A4-4A64-A778-DEF721AFA258
author name string	Amparo Estellés Cristina Falcó Justo Aznar Esther Zorio Luis Almenar Ana Osa Remedios Castelló
rdfs:label	Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (en) Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (nl)
skos:prefLabel	Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (en) Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (nl)
name	Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (en) Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (nl)
author	wds:Q73903671-E56F8BD3-2F56-44E4-BBA7-264BD32C3682
author	Francisco España
title	wds:Q73903671-7C590FB2-5833-477E-8AD4-09E2591A4234
title	Thrombin-activatable fibrinolysis inhibitor in young patients with myocardial infarction and its relationship with the fibrinolytic function and the protein C system (en)
page(s)	wds:Q73903671-4F9F4350-06F5-4D5D-8515-449F36B79001
page(s)	958-965
instance of	wds:Q73903671-7AE358D5-9541-43AB-AC12-FDA2447E33CC
instance of	scholarly article
main subject	wds:Q73903671-60FFE45C-C558-41EF-92C8-E5FFFA627941
main subject	myocardial infarction
PubMed ID	wds:Q73903671-8F4D7E89-C213-460C-A3E4-B528C08065FA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/12956767
PubMed ID	12956767
published in	wds:Q73903671-5B8B1B3B-AE80-4CC1-B145-327801A44D09
published in	British Journal of Haematology
issue	wds:Q73903671-61E6731D-5BA7-46AF-95C7-44818821D371
volume	wds:Q73903671-A918F27E-ED8F-4D6D-BF72-61F1CD713878
issue	6
volume	122
DOI	wds:Q73903671-3372A784-1F71-44C5-AB4F-94EC4790090D
DOI	http://dx.doi.org/10.1046/J.1365-2141.2003.04549.X
DOI	10.1046/J.1365-2141.2003.04549.X
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q73903671
is cites work of	Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease The fibrinogen γA/γ' isoform does not promote acute arterial thrombosis in mice Low thrombin activatable fibrinolysis inhibitor activity levels are associated with an increased risk of a first myocardial infarction in men Deficiency in thrombin-activatable fibrinolysis inhibitor (TAFI) protected mice from ferric chloride-induced vena cava thrombosis Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation The effect of genetic variants in the thrombin activatable fibrinolysis inhibitor (TAFI) gene on TAFI-antigen levels, clot lysis time and the risk of venous thrombosis Dose-Response Relationship Between Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) and Stroke: A Chinese Case-Control Study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 180 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software